Impact of burn injury on hepatic TGF-β1 expression and plasma TGF-β1 levels
暂无分享,去创建一个
[1] D. Brenner,et al. NFkappaB prevents apoptosis and liver dysfunction during liver regeneration. , 1998, The Journal of clinical investigation.
[2] M Chrétien,et al. Pro‐protein convertase gene expression in human breast cancer , 1997, International journal of cancer.
[3] K. Meert,et al. Elevated transforming growth factor-beta concentration correlates with posttrauma immunosuppression. , 1996, The Journal of trauma.
[4] S. Werner,et al. Transforming Growth Factors 1, 2, and 3 and Their Receptors Are Differentially Regulated during Normal and Impaired Wound Healing (*) , 1996, The Journal of Biological Chemistry.
[5] S. Kobayashi,et al. Role of transforming growth factor beta 1 on hepatic regeneration and apoptosis in liver diseases. , 1995, Journal of clinical pathology.
[6] D M Bissell,et al. Cell-specific expression of transforming growth factor-beta in rat liver. Evidence for autocrine regulation of hepatocyte proliferation. , 1995, The Journal of clinical investigation.
[7] D. Schiffer,et al. A Study of Apoptosis in Normal and Pathologic Nervous Tissue After In situ End‐Labeling of DNA Strand Breaks , 1994, Journal of neuropathology and experimental neurology.
[8] F. Ponchel,et al. Hepatocarcinoma-specific mutant p53-249ser induces mitotic activity but has no effect on transforming growth factor beta 1-mediated apoptosis. , 1994, Cancer research.
[9] W. Bursch,et al. Apoptosis is induced by transforming growth factor‐β1 within 5 hours in regressing liver without significant fragmentation of the DNA , 1993, Hepatology.
[10] A. Wyllie,et al. Apoptosis (the 1992 Frank Rose Memorial Lecture). , 1993, British Journal of Cancer.
[11] M. Sporn,et al. Transforming growth factor-beta: recent progress and new challenges , 1992, The Journal of cell biology.
[12] R. Pollard,et al. Transforming growth factor- in the regulation of the immune response , 1992 .
[13] F. Weiner,et al. Increased transforming growth factor-β1 gene expression in human liver disease , 1992 .
[14] S. Wahl. Transforming growth factor beta (TGF-beta) in inflammation: a cause and a cure. , 1992, Journal of clinical immunology.
[15] H. Stein,et al. Transforming growth factors beta 1 and beta 2 are differentially expressed in fibrotic liver disease. , 1991, The American journal of pathology.
[16] J. Massagué,et al. Early gene responses to transforming growth factor-beta in cells lacking growth-suppressive RB function , 1991, Molecular and cellular biology.
[17] J. Azizkhan,et al. Induction of NF-kappa B DNA-binding activity during the G0-to-G1 transition in mouse fibroblasts , 1991, Molecular and cellular biology.
[18] W. Bursch,et al. Effect of transforming growth factor beta on cell death of cultured rat hepatocytes. , 1991, Cancer research.
[19] S. Thorgeirsson,et al. Transforming growth factor-beta 1 and type I procollagen transcripts during regeneration and early fibrosis of rat liver. , 1990, Laboratory investigation; a journal of technical methods and pathology.
[20] S. Thorgeirsson,et al. Cellular distribution of transforming growth factor-beta 1 and procollagen types I, III, and IV transcripts in carbon tetrachloride-induced rat liver fibrosis. , 1990, The Journal of clinical investigation.
[21] A. Boobis,et al. Mechanisms of cell death. , 1989, Trends in pharmacological sciences.
[22] M. Czaja,et al. In vitro and in vivo association of transforming growth factor-beta 1 with hepatic fibrosis , 1989, The Journal of cell biology.
[23] M. A. Hayes,et al. Inhibition of proliferation of normal, preneoplastic, and neoplastic rat hepatocytes by transforming growth factor-beta. , 1987, Cancer research.
[24] R. Coffey,et al. Hepatic processing of transforming growth factor beta in the rat. Uptake, metabolism, and biliary excretion. , 1987, The Journal of clinical investigation.
[25] P. Chomczyński,et al. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.
[26] S. Thorgeirsson,et al. Differential effects of transforming growth factor-beta on proliferation of normal and malignant rat liver epithelial cells in culture. , 1986, Cancer research.
[27] H. Moses,et al. Inhibition of DNA Synthesis in rat hepatocytes by Platelet-derived Type β Transforming Growth Factor , 1986 .
[28] T. Nakamura,et al. Inhibitory effect of transforming growth factor-beta on DNA synthesis of adult rat hepatocytes in primary culture. , 1985, Biochemical and biophysical research communications.
[29] W. Bursch,et al. Controlled death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promoters. , 1984, Carcinogenesis.
[30] J F Kerr,et al. Shrinkage necrosis: A distinct mode of cellular death , 1971, The Journal of pathology.
[31] V. Paradis,et al. Transforming growth factor-beta (TGF-beta): a key-role in liver fibrogenesis. , 1995, Journal of hepatology.
[32] W. Bursch,et al. Cell death by apoptosis and its protective role against disease. , 1992, Trends in pharmacological sciences.
[33] M. Czaja,et al. Expression of Tumor Necrosis Factor-α and Transforming Growth Factor-β1 in Acute Liver Injury , 1989 .
[34] W. Russell. Transforming growth factor beta (TGF-beta) inhibits hepatocyte DNA synthesis independently of EGF binding and EGF receptor autophosphorylation. , 1988, Journal of cellular physiology.
[35] A. Wyllie,et al. Cell death: the significance of apoptosis. , 1980, International review of cytology.